Previous 10 | Next 10 |
Oncology-Focused Therapeutic Solutions International Subsidiary Seeks to Enter Clinical Trials of “Repurposed” Abortion Pill for Breast Cancer The original source-language text of this announcement is the official, authoritative version. Translations are provided as an acc...
Therapeutic Solutions International, Inc. (TSOI) announced today a patent filing covering the unanticipated finding that neutrophils, a type of white blood cell, when manufactured in a specific manner, are capable of stopping unwanted immune responses while allowing the body to fight bacteria and...
Appointment of Dr. Navneet Boddu to Expand Patient Access to Stem Cells in FDA Compliant Manner Therapeutic Solutions International, Inc. (TSOI), announced today the appointment of internationally renowned stem cell therapist Dr. Navneet Boddu to the Company’s Scientific Advisory...
Stem Cell Modification of Cancer Microenvironment Shown to Increase Ability of Immune System to Stop Breast Cancer Therapeutic Solutions International, Inc. (TSOI) announced today new data and a patent filing from its Subsidiary Company Res Nova Bio which, according to Company scientist...
Res Nova Bio Reports Landmark Oncology Findings Supporting Clinical Translation of its Pterostilbene-Abortion Pill Cancer Adjuvant Therapeutic Solutions International, Inc. (TSOI) reported that its breast cancer immunotherapy spin-off company, Res Nova Bio, released data showing synergi...
Therapeutic Solutions International, Inc. (TSOI), announced today issuance of a Notice of Allowance from the United States Patent and Trademark Office on its patent application covering a novel composition of matter being developed for prevention of suicide. Campbell Neuroscience has been foc...
Protection of T Cells from Tumor-Induced Suppression Suggests Potential for Enhancing Efficacy of Checkpoint Inhibitor and CAR-T Therapies Company Plans to Initiate Phase I/II Clinical Trial in Advanced Breast Cancer Patients Therapeutic Solutions International, Inc. (TSOI), ann...
Clinical Stage Biotech Company Leverages Existing Clinical Data and Phase III Clearance to Accelerate Treatment of Fatal Lung Condition Therapeutic Solutions International (TSOI) announced today filing with the FDA for Orphan Drug Designation for its JadiCell Adult Stem Cell Product for...
ValloVax Cancer Endothelial Stem Cell Technology Repositioned to Overcome Limitations on Multibillion Dollar Cancer Immunotherapy Market Therapeutic Solutions International (TSOI) announced today its Spin-Off Company, Res Nova Bio, achieved successful delivery of a cancer killing virus ...
Clinical Stage Biotech Company Partners with Premier Compounding Pharmacy to Provide Doses for IRB Cleared Phase I/II Clinical Trial Therapeutic Solutions International (TSOI) spin-off Res Nova Bio announced today a collaboration with Cure Stat Rx, a premiere compounding Pharmacy in the...
News, Short Squeeze, Breakout and More Instantly...
Therapeutic Sltns Intl Company Name:
TSOI Stock Symbol:
OTCMKTS Market:
Clinical Stage Stem Cell Company Granted Exclusivity on the Use of Specific Immune System Cells to Increase Efficacy of Stem Cells in Lung Inflammation Therapeutic Solutions International, Inc. (TSOI) announced today receipt of a Notice of Allowance from the United States Patent and Tra...
Therapeutic Solutions International Pre-Spin-Off Company Plans to Enter Capital Markets Through Partial Distribution of its Shares to Shareholders of Parent Company Therapeutic Solutions International, Inc. (TSOI) Pre-Spin-Off Company Plans to Enter Capital Markets Through Partial Distr...
Latest Patent to Complement Issued Claims on Viral Inhibition, Adaptive Immune Stimulation, and Brain Protection/Regeneration Therapeutic Solutions International, Inc. (TSOI), a clinical-stage stem cell and immunotherapy company, announced today the granting of a patent covering the abi...